BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benetó N, Vilageliu L, Grinberg D, Canals I. Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches. Int J Mol Sci 2020;21:E7819. [PMID: 33105639 DOI: 10.3390/ijms21217819] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ballantyne M, Chiu B, Sergi CM. Sanfilippo Syndrome Type A: Early Cardiac Involvement of Two patients with Cardiac Manifestations. Cardiovascular Pathology 2022. [DOI: 10.1016/j.carpath.2022.107430] [Reference Citation Analysis]
2 Santos JI, Gonçalves M, Matos L, Moreira L, Carvalho S, Prata MJ, Coutinho MF, Alves S. Splicing Modulation as a Promising Therapeutic Strategy for Lysosomal Storage Disorders: The Mucopolysaccharidoses Example. Life 2022;12:608. [DOI: 10.3390/life12050608] [Reference Citation Analysis]
3 Bruno LP, Fava F, Baldassarri M, Salvati VM, Scandurra V, Canitano R, Valentino F, Doddato G, Tita R, Giliberti A, Renieri A, Ariani F. Identification of a Novel Pathogenic Variant in the NAGLU Gene in a Child with Neurodevelopmental Delay. J Autism Dev Disord 2021. [PMID: 34709531 DOI: 10.1007/s10803-021-05332-x] [Reference Citation Analysis]
4 Değerliyurt A, Yayıcı Köken Ö, Teker ND, Aktaş D. Significant neuropsychiatric symptoms: three mucopolysaccharidosis type IIIB cases, two of whom were siblings with a novel NAGLU gene mutation. Neurocase 2021;:1-6. [PMID: 34396902 DOI: 10.1080/13554794.2021.1966046] [Reference Citation Analysis]
5 De Pasquale V, Scerra G, Scarcella M, D'Agostino M, Pavone LM. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB. Biochim Biophys Acta Mol Cell Res 2021;1868:119113. [PMID: 34329663 DOI: 10.1016/j.bbamcr.2021.119113] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Barone R, Fiumara A, Gulisano M, Cirnigliaro L, Cocuzza MD, Guida C, Pettinato F, Greco F, Elia M, Rizzo R. Electroclinical Features of Epilepsy in Mucopolysaccharidosis III: Outcome Description in a Cohort of 15 Italian Patients. Front Neurol 2021;12:705423. [PMID: 34349725 DOI: 10.3389/fneur.2021.705423] [Reference Citation Analysis]
7 Atienza J, Tkachyova I, Tropak M, Fan X, Schulze A. Fluorometric coupled enzyme assay for N-sulfotransferase activity of N-deacetylase/N-sulfotransferase (NDST). Glycobiology 2021:cwab048. [PMID: 34080004 DOI: 10.1093/glycob/cwab048] [Reference Citation Analysis]
8 Gougeon ML, Poirier-Beaudouin B, Ausseil J, Zérah M, Artaud C, Heard JM, Deiva K, Tardieu M. Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome. Front Immunol 2021;12:655478. [PMID: 34040605 DOI: 10.3389/fimmu.2021.655478] [Cited by in F6Publishing: 1] [Reference Citation Analysis]